Dr. Michael A Rausch
Claim this profileGSK Investigational Site
Affiliated Hospitals
Alliance For Multispecialty Research, LLC
Alliance For Multispecialty Research, LLC El Dorado
Clinical Trials Michael A Rausch is currently running
New Vaccine
for Flu
The aim of this study is to evaluate the safety, reactogenicity and immunogenicity of the Flu Pandemic messenger RNA (mRNA) vaccine (including dose-finding and dose-confirmation) administered in healthy adults 18 to 85 years of age.
Recruiting
0 awards
Phase 1 & 2
3 criteria
RSV Vaccine
for Adults 60+
The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 consecutive RSV seasons (approximately 60 months) of a single dose of RSVPreF3 OA vaccine, * To give the opportunity to participants who received only placebo in the RSVOA=ADJ- 006 study, to receive a dose of the RSVPreF3 OA vaccine and collect additional safety information.
Recruiting
2 awards
Phase 3
1 criteria
More about Michael A Rausch
Clinical Trial Related
5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Michael A Rausch has experience with
- RSVPreF3 OA Vaccine
- Orforglipron
- Insulin Glargine
- Gepotidacin
- Nitrofurantoin
- Meningococcal MenACWY Conjugate Vaccine (GSK3536820A) (MenA Lyo + MenCWY Liquid)
Breakdown of trials Michael A Rausch has run
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael A Rausch specialize in?
Michael A Rausch focuses on Respiratory Syncytial Virus Infection and Respiratory Syncytial Virus. In particular, much of their work with Respiratory Syncytial Virus Infection has involved treating patients, or patients who are undergoing treatment.
Is Michael A Rausch currently recruiting for clinical trials?
Yes, Michael A Rausch is currently recruiting for 2 clinical trials in El Dorado Kansas. If you're interested in participating, you should apply.
Are there any treatments that Michael A Rausch has studied deeply?
Yes, Michael A Rausch has studied treatments such as RSVPreF3 OA vaccine, Orforglipron, Insulin Glargine.
What is the best way to schedule an appointment with Michael A Rausch?
Apply for one of the trials that Michael A Rausch is conducting.
What is the office address of Michael A Rausch?
The office of Michael A Rausch is located at: GSK Investigational Site, El Dorado, Kansas 67042 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.